145 filings
Page 2 of 8
DEFA14A
wmr2nqxpysfxt2igfimh
22 Dec 23
Additional proxy soliciting materials
5:20pm
8-K
25py818
22 Dec 23
Entry into a Material Definitive Agreement
5:07pm
DFAN14A
blq07gtl
22 Dec 23
Additional proxy materials by non-management
4:36pm
DEFA14A
r16nxgmb 7qu
22 Dec 23
Additional proxy soliciting materials
4:28pm
DEFA14A
hpza9xqokv2418zd
22 Dec 23
Additional proxy soliciting materials
4:22pm
DFAN14A
5kvlm3q08 fgp2d
22 Dec 23
Additional proxy materials by non-management
4:21pm
DEFA14A
7c10q8gqrxmnyfk
22 Dec 23
Additional proxy soliciting materials
4:12pm
DEFA14A
v2vedeokxy
22 Dec 23
Additional proxy soliciting materials
8:31am
8-K
38j2p4p
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
8:26am
8-K
zs6k6rr1r6y
2 Nov 23
Karuna Therapeutics Reports Third Quarter 2023 Financial Results and Provides General Business Updates
6:36am
8-K
gneuw
3 Aug 23
Karuna Therapeutics Reports Second Quarter 2023 Financial Results and Provides General Business Updates
6:37am
S-3ASR
rkj ygbbdg
21 Jun 23
Automatic shelf registration
5:15pm
8-K
w9hu95 tb
21 Jun 23
Termination of a Material Definitive Agreement
4:05pm
8-K
79vo9
4 May 23
Karuna Therapeutics Reports First Quarter 2023 Financial Results and Provides General Business Updates
6:37am
ARS
9ud3lf2ytv9igsdgcha
27 Apr 23
Annual report to shareholders
7:12am
DEFA14A
5ey9gsizdh4
27 Apr 23
Additional proxy soliciting materials
6:58am